Ulrik Ringborg

NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.

Katarina Omholt, Anton Platz, Lena Kanter et al. · PubMed · 2003 · 401 citations

European Code Against Cancer and scientific justification: third version (2003)

Peter Boyle, Philippe Autier, Harry Bartelink et al. · Annals of Oncology · 2003 · 307 citations · Full text

Oncology, Cancer Epidemiology, Scientific Justification +9

Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm

Gabriella Cohn‐Cedermark, Lars Erik Rutqvist, Ronny Andersson et al. · Cancer · 2000 · 304 citations

Surgical Oncology, Medicine, Cancer Recurrence +15

2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial

Peter Gillgren, Krzysztof T. Drzewiecki, Marianne Niin et al. · The Lancet · 2011 · 227 citations

Surgical Oncology, Melanoma, Multicentre Trial +5

Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females

Boel Ragnarsson-Olding, Lena Kanter‐Lewensohn, Bengt Lagerl�f et al. · Cancer · 1999 · 182 citations · Full text